Search / Trial NCT06227572

Cognition After OSA Treatment Among Native American People (CATNAP)

Launched by WASHINGTON STATE UNIVERSITY · Jan 25, 2024

Trial Information

Current as of October 04, 2024

Not yet recruiting

Keywords

Description

The investigators will develop a multilevel 9-month culturally informed motivational interviewing and electronic messaging intervention- "Cognition After Obstructive Sleep Apnea (OSA) Among Native American People" (CATNAP) to: 1) provide participants with Motivational Interviewing sessions to address obstructive sleep apnea (OSA), positive airway pressure (PAP) adherence, and risk of Alzheimer's disease and related dementias (ADRD) in American Indians and 2) provide participants with electronic messaging to support PAP adherence among American Indian elders, aged 50 years and older. This s...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Age 50 years and older
  • * Self report American Indian or Alaskan Native
  • * diagnosed with obstructive sleep apnea
  • * prescribed PAP therapy and have a device
  • * \*Ability to understand written and spoken English; and
  • * \*Ability and willingness to follow all study protocols.
  • Exclusion Criteria:
  • * Living in a household with someone who is enrolled in the study
  • * Already using PAP device at Medicaid recommended standards
  • * Cognitive decline, unable to consent on their own

About Sponsor

The National Institute of Allergy and Infectious Diseases (NIAID, /ˈnaɪ.æd/) is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.

Contacts

JC

Jennifer Cobb

Immunology at National Institute of Allergy and Infectious Diseases (NIAID)

Locations

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0